Abbvie completes Capstan Therapeutics acquisition

Remegen's Telitacicept meets Sjogren's syndrome Phase III trial's primary endpoint

Novartis reports positive Phase III trial results for ianalumab in immune thrombocytopenia

Novartis reports positive Phase III results for ianalumab in Sjögren's disease

US FDA approves Innovent's IND application for IBI3032 oral GLP-1R agonist

Formation Bio licenses IMIDomics' anti-CD226 autoimmune programme

Hemogenyx wins USD120,000 grant to advance scalable CAR-T manufacturing

IGI and AbbVie enter global licensing agreement for ISB 2001

Orsini named KalVista's specialty pharmacy partner for EKTERLY (sebetralstat)

Jacobio's JAB-8263 Phase I/II Clinical Trial IND application receives Chinese regulatory approval

AbbVie agrees to acquire Capstan Therapeutics

Sanofi's riliprubart receives orphan drug designation in Japan for CIDP

Galderma launches two phase II trials for nemolizumab in systemic sclerosis and chronic pruritus of unknown origin

Innovent presents mazdutide Phase 3 clinical study results at ADA 85th Scientific Sessions

Harbour BioMed and Otsuka collaborate on advancing BCMAxCD3 bispecific T-cell engagers